Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-031566
Filing Date
2019-06-19
Accepted
2019-06-19 20:34:21
Documents
1
Period of Report
2019-06-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv523895_4.html 4  
1 OWNERSHIP DOCUMENT tv523895_4.xml 4 4093
  Complete submission text file 0001144204-19-031566.txt   5783
Mailing Address C/O AEOLUS PHARMACEUTICALS, INC. 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address
RALLIS CHRIS A (Reporting) CIK: 0001185945 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 19907288

Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)